While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...

Everyone has probably dealt with at least a little physical pain in their life.But fortunately, the number of peop ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Best TENS machines for effective chronic pain relief - Discover the benefits and drawbacks of using electrical nerve ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

Our understanding of pain, and especially chronic pain, is far behind where it should be. We don’t know what causes a person with an injury to develop chronic pain, or why it happens in some ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.